{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:31Z","timestamp":1791356191477,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jaad.2015.11.043","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T21:31:51Z","timestamp":1452807111000},"page":"974-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Use of tumor necrosis factor (TNF) inhibitors in patients with HIV\/AIDS"],"prefix":"10.1016","volume":"74","author":[{"given":"Stephanie M.","family":"Gallitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaljit","family":"Brar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2015.11.043_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.rhu.0000260411.75599.39","article-title":"Successful etanercept use in an HIV-positive patient with rheumatoid arthritis","volume":"13","author":"Kaur","year":"2007","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2015.11.043_bib2","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumor necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2015.11.043_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1758-2652-14-5","article-title":"New insights into HIV-1-primary skin disorders","volume":"14","author":"Cedeno-Laurent","year":"2011","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"10.1016\/j.jaad.2015.11.043_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","article-title":"HIV-associated psoriasis: pathogenesis, clinical features, and management","volume":"10","author":"Morar","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.043_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-200401230-00015","article-title":"A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis","volume":"18","author":"Wallis","year":"2004","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jaad.2015.11.043_bib6","first-page":"869","article-title":"Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient","volume":"13","author":"Lindsey","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.043_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jbspin.2006.05.012","article-title":"Use of infliximab to treat psoriatic arthritis in HIV-positive patients","volume":"74","author":"Sellam","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.jaad.2015.11.043_bib8","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1073\/pnas.86.7.2336","article-title":"Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B","volume":"86","author":"Osborn","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.043_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.jaad.2015.11.043_bib10","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2015.11.043_bib11","doi-asserted-by":"crossref","first-page":"484378","DOI":"10.1155\/2013\/484378","article-title":"TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?","volume":"2013","author":"Kumar","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.jaad.2015.11.043_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/infdis\/174.1.63","article-title":"Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1","volume":"174","author":"Walker","year":"1996","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.jaad.2015.11.043_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/088922202760019365","article-title":"Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2","volume":"18","author":"Sha","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.043_bib14","first-page":"29","article-title":"Is there a potential role for anti-tumor necrosis factor therapy in patients with human immunodeficiency virus?","volume":"2","author":"Emer","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.043_bib15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-4632.2005.02642.x","article-title":"Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients","volume":"45","author":"Ting","year":"2006","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.11.043_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2036.2009.04112.x","article-title":"Review article: chronic viral infection in the anti-tumor necrosis factor therapy era in inflammatory bowel disease","volume":"31","author":"Shale","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jaad.2015.11.043_bib17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","article-title":"Granulomatous infections due to tumor necrosis factor blockade: correction","volume":"39","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jaad.2015.11.043_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/75.10.1093","article-title":"Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis","volume":"75","author":"Aboulafia","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.043_bib19","first-page":"407","article-title":"Infliximab in the treatment of an HIV positive patient with Reiter's syndrome","volume":"30","author":"Gaylis","year":"2003","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.043_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/RHU.0b013e31824e9151","article-title":"Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab","volume":"18","author":"Gaylis","year":"2012","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.043_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.0007-0963.2004.05885.x","article-title":"Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab","volume":"150","author":"Bartke","year":"2004","journal-title":"Br J Dermatol"},{"issue":"16","key":"10.1016\/j.jaad.2015.11.043_bib22","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1001\/archinte.166.16.1783","article-title":"Infliximab and human immunodeficiency virus infection: viral load reduction and CD4+ T-cell loss related to apoptosis","volume":"166","author":"Filippi","year":"2006","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.jaad.2015.11.043_bib23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gut.2006.101386","article-title":"Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease","volume":"55","author":"Beltr\u00e1n","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jaad.2015.11.043_bib24","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.043_bib25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2007.081513","article-title":"The use of\u00a0anti-tumor necrosis factor therapy in HIV-positive individuals with rheumatic disease","volume":"67","author":"Cepeda","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.043_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archderm.144.4.453","article-title":"Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus","volume":"144","author":"Mikhail","year":"2008","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.043_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.crohns.2009.04.004","article-title":"Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab","volume":"3","author":"Carri\u00f3n","year":"2009","journal-title":"J Crohns Colitis"},{"issue":"12","key":"10.1016\/j.jaad.2015.11.043_bib28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archdermatol.2010.372","article-title":"Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab","volume":"146","author":"Alecsandru","year":"2010","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2015.11.043_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/apc.2011.0158","article-title":"Severe hidradenitis suppurative in an HIV-positive male: use of multiple treatment modalities, including tumor necrosis factor blockade","volume":"25","author":"Husein-ElAhmed","year":"2011","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.jaad.2015.11.043_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jbspin.2013.01.002","article-title":"Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia","volume":"80","author":"Almoallim","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.jaad.2015.11.043_bib31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4103\/0378-6323.110807","article-title":"Long-term management of HIV\/hepatitis C virus associated psoriasis with etanercept","volume":"79","author":"Di Lernia","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"10.1016\/j.jaad.2015.11.043_bib32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/CVI.00081-13","article-title":"Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report","volume":"20","author":"De Nardo","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2015.11.043_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2009.03.047","article-title":"Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation","volume":"62","author":"Menon","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215025232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215025232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:38:55Z","timestamp":1759271935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215025232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0190962215025232"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.043","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of tumor necrosis factor (TNF) inhibitors in patients with HIV\/AIDS","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}